Day: January 4, 2021

Griffin Announces Corporate Updates and New Name

Written by Customer Service on January 4, 2021. Posted in Public Companies.

NEWS FROM: INDUS REALTY TRUST, INC. (formerly GRIFFIN INDUSTRIAL REALTY, INC.)Completion of Maryland reincorporationName change from Griffin Industrial Realty, Inc. to INDUS Realty Trust, Inc. and change in trading symbol from “GRIF” to “INDT”REIT conversion effective January 1, 2021 NEW YORK, Jan. 04, 2021 (GLOBE NEWSWIRE) — Griffin Industrial Realty, Inc. (Formerly Nasdaq: GRIF) announced the following corporate updates concerning its reincorporation as a Maryland corporation, the adoption of a new name and trading symbol and the start of operations as a real estate investment trust (“REIT”) on January 1, 2021.“I am excited to announce the completion of a number of strategic milestones as we start the new year,” said Michael Gamzon, President & Chief Executive Officer. “We look forward...

FLEURY MICHON : Déclaration des opérations de rachat d’actions du 28 au 31 décembre 2020

Written by Customer Service on January 4, 2021. Posted in Public Companies.

PROGRAMME DE RACHATDECLARATION DES TRANSACTIONS SUR ACTIONS PROPRESSOCIETE FLEURY MICHONPrésentation agrégée par jour et par marchéPériode : 28/12/2020 au 31/12/2020Détail transaction par transactionPièce jointeDéclaration Transactions du 28 au 31 décembre 2020

RenalytixAI to Present at the 39th Annual J.P. Morgan Healthcare Conference

Written by Customer Service on January 4, 2021. Posted in Public Companies.

NEW YORK, Jan. 04, 2021 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today announced the company will be presenting at the upcoming 39th Annual J.P. Morgan Virtual Healthcare Conference.RenalytixAI’s management is scheduled to present on Wednesday, January 13 at 10:00 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at investors.renalytixai.com.About RenalytixAIRenalytixAI is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical...

urban-gro, Inc. Reports Preliminary Fourth Quarter and Fiscal Year 2020 Results

Written by Customer Service on January 4, 2021. Posted in Public Companies.

Record Q4 2020 revenues of $9.0 million to $9.3 million, which would represent an increase of at least $2.9 million (26%) from revenues of $7.1 million reported in Q4 2019.Record 2020 revenues of $25.6 million to $25.9 million, which would represent an increase of at least $1.4 million (6%) from revenues of $24.2 million reported in 2019.Net loss for Q4 2020 of negative ($1.7) million to negative ($1.4) million, which would represent an improvement of at least $0.9 million from net loss of negative ($2.6) million in Q4 2019.Net loss for 2020 of negative ($5.7) million to negative ($5.4) million, which would represent an improvement of at least $2.7 million from net loss of negative ($8.4) million in 2019.Company expects to achieve positive Adjusted EBITDA for the second quarter in a row and achieve full-year 2020 Adjusted EBITDA of negative...

Selecta Biosciences to Participate in the H.C. Wainwright BioConnect 2021 Conference

Written by Customer Service on January 4, 2021. Posted in Public Companies.

WATERTOWN, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that Selecta’s Chief Executive Officer, Carsten Brunn, Ph.D., and Chief Financial Officer, Brad Dahms, will participate in the virtual H.C. Wainwright BioConnect 2021 Conference to be held January 11-14, 2021.The presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 6 a.m. EST on Monday, January 11, 2021.A webcast will also be available in the Investors & Media section of the company’s website at www.selectabio.com.About Selecta Biosciences, Inc.Selecta Biosciences Inc. (NASDAQ: SELB) is leveraging its clinically...

89bio to Participate in the H.C. Wainwright BioConnect 2021 Conference

Written by Customer Service on January 4, 2021. Posted in Public Companies.

SAN FRANCISCO, Jan. 04, 2021 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced that Rohan Palekar, the company’s Chief Executive Officer, will provide a corporate update at the virtual H.C. Wainwright BioConnect 2021 Conference to be held January 11-14, 2021.The presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 6 a.m. EST on Monday, January 11, 2021. An archived webcast will also be accessible in the investor section of 89bio’s website.About 89bio89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver...

Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January

Written by Customer Service on January 4, 2021. Posted in Public Companies.

NEWTON, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced that company management will participate in two upcoming investor conferences in January:H.C. Wainwright Bioconnect 2021 ConferenceLouis Brenner, M.D., Allena’s President and Chief Executive Officer, will participate in a pre-recorded fireside chat, which will become available for on-demand viewing at 6:00 a.m. ET on Monday, January 11, 2021.15thAnnual Stern IR Corporate Access EventLouis Brenner, M.D., Allena’s President and Chief Executive Officer, will pre-record a corporate overview, which will become available for on-demand...

Watsco Declares $1.775 Quarterly Dividend 47th Consecutive Year of Paying Dividends

Written by Customer Service on January 4, 2021. Posted in Dividend Reports And Estimates.

MIAMI, Jan. 04, 2021 (GLOBE NEWSWIRE) — Watsco, Inc.’s (NYSE: WSO) Board of Directors has declared a regular quarterly cash dividend of $1.775 on each outstanding share of its Common and Class B common stock payable on January 29, 2021 to shareholders of record at the close of business on January 15, 2021.Watsco has paid dividends for 47 consecutive years. The Company’s philosophy is to share increasing amounts of cash flow with shareholders through higher dividends while maintaining a conservative financial position. Future dividends will be considered in light of investment opportunities, cash flow, general economic conditions and the Company’s financial condition.About WatscoWatsco is the largest distribution network for heating, air conditioning and refrigeration (HVAC/R) products with locations in the United States, Canada, Mexico and Puerto...

ATN International, Inc. Announces Agreement to Acquire Alaska Communications

Written by Customer Service on January 4, 2021. Posted in Mergers And Acquisitions.

BEVERLY, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) — ATN International, Inc. (NASDAQ: ATNI) (“ATN”) announced today that it has agreed to acquire Alaska Communications Systems Group, Inc. (NASDAQ: ALSK) (“Alaska Communications”) in an all cash transaction valued at approximately $332.0 million, including outstanding net debt. ATN and financial partner Freedom 3 Capital, LLC (“F3C”) created a newly formed entity that has entered into a definitive agreement to acquire all the outstanding shares of Alaska Communications common stock for $3.40 per share in cash. ATN will operate and consolidate the new entity and Alaska Communications through its majority ownership stake.Michael Prior, Chairman and Chief Executive Officer of ATN, stated, “This investment and merger allows us to enter a new market with many similar characteristics to our...

MNP LTD Acquires Beth Maynard & Associates Inc in Sudbury

Written by Customer Service on January 4, 2021. Posted in Mergers And Acquisitions.

CALGARY, Alberta, Jan. 04, 2021 (GLOBE NEWSWIRE) — MNP LTD. acquires Beth Maynard & Associates Inc, a consumer insolvency practice based in Sudbury, Ontario, effective January 1, 2021.“This acquisition will continue to help our firm achieve its strategic goal of offering more individuals consumer insolvency services and tailored debt solutions,” said Grant Bazian, Licensed Insolvency Trustee and the President of MNP LTD.“MNP is very excited about this acquisition as it immediately expands our presence into the Sudbury and North Bay areas in conjunction with new locations in Elliot Lake and Blind River,” said Grant Bazian. “Further expansion into Sault Ste Marie and Timmins is slated to follow.”Established in 2009, Beth Maynard & Associates has been serving clients in Northern Ontario for 12 years. Beth started the practice...

Day: January 4, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals